CASD1 and breast cancer: Here, we show that O-acetylation of gangliosides is not dependent on the level of CASD1, but much more dependent on the availability of ganglioside substrate and acetyl-CoA availability as underlined by the acetyl-CoA transporter SLC33A1 upregulation, regardless of the BC cell lines.